Differential regulation of proliferation, cell cycle control and gene expression in cultured human aortic and pulmonary artery endothelial cells by resveratrol

International Journal of Molecular Medicine

Volumn 26, Issue 5, 2010, Pages 743-749

  Hsieh, Tze Chen ^a   Lu, Xiaohua ^a   Guo, Junqiao ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cell cycle control; Cell proliferation; Human aortic endothelial cells; Human pulmonary aortic endothelial cells; Resveratrol

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; HEAT SHOCK PROTEIN 27; HEPATOCYTE NUCLEAR FACTOR 3BETA; MESSENGER RNA; PREPROENDOTHELIN 1; PROTEIN BCL XL; PROTEIN C JUN; PROTEIN MDM2; PROTEIN P57; PROTEIN PATCHED 1; RESVERATROL; TRANSCRIPTION FACTOR CDX1;

AORTA; ARTICLE; CELL CULTURE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULMONARY ARTERY; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM;

AORTA; CELL CYCLE; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; PLATELET AGGREGATION INHIBITORS; PULMONARY ARTERY; SIGNAL TRANSDUCTION; STILBENES;

EID: 77957875108     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000521     Document Type: Article

References (45)

1. Murray CJ, Kulkarni SC and Ezzati M: Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States. Circulation 113: 2071-2081, 2006. (Pubitemid 43755157)
2. Mathers CD and Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442, 2006.
3. Murray CJ, Lopez AD, Black R, et al: Global burden of disease 2005: call for collaborators. Lancet 370: 109-110, 2007.
4. Danaei G, Ding EL, Mozaffarian D, et al: The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 6: e1000058, 2009.
5. Rizzo M, Corrado E, Coppola G, Muratori I, Novo G and Novo S: Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis 200: 389-395, 2008.
6. Mullenix PS, Steele SR, Martin MJ, Starnes BW and Andersen CA: C-reactive protein level and traditional vascular risk factors in the prediction of carotid stenosis. Arch Surg 142: 1066-1071, 2007.
7. Carter SJ, Roberts MB, Salter J and Eaton CB: Relationship between Mediterranean Diet Score and atherothrombotic risk: findings from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Atherosclerosis 210: 630-636, 2010.
8. Das S, Lekli I, Das M, et al: Cardioprotection with palm oil tocotrienols: comparision of different isomers. Am J Physiol Heart Circ Physiol 294: H970-H978, 2008.
9. Shukla SK, Gupta S, Ojha SK and Sharma SB: Cardiovascular friendly natural products: a promising approach in the management of CVD. Nat Prod Res 24: 873-898, 2010.
10. Bertelli AA and Das DK: Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 54: 468-476, 2009.
11. Renaud S and de Lorgeril M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526, 1992.
12. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG and Huang YZ: Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int J Mol Med 8: 3-17, 2001.
13. Collins MA, Neafsey EJ, Mukamal KJ, et al: Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 33: 206-219, 2009.
14. Vidavalur R, Otani H, Singal PK and Maulik N: Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 11: 217-225, 2006. (Pubitemid 44540866)
15. Zou J, Huang Y, Chen Q, Wei E, Cao K and Wu JM: Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin Med J 113: 99-102, 2000. (Pubitemid 30176438)
16. Belguendouz L, Fremont L and Linard A: Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 53: 1347-1355, 1997.
17. Zou J, Huang Y, Chen Q, et al: Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells. Int J Oncol 15: 647-651, 1999.
18. Poussier B, Cordova AC, Becquemin JP and Sumpio BE: Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg 42: 1190-1197, 2005.
19. Brito PM, Devillard R, Negre-Salvayre A, et al: Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis 205: 126-134, 2009.
20. Wang Z, Zou J, Huang Y, Cao K, Xu Y and Wu JM: Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin Med J 115: 378-380, 2002. (Pubitemid 34272437)
21. Kirk RI, Deitch JA, Wu JM and Lerea KM: Resveratrol decreases early signaling events in washed platelets but has little effect on platalet in whole food. Blood Cells Mol Dis 26: 144-150, 2000.
22. Lin KH, Hsiao G, Shih CM, Chou DS and Sheu JR: Mechanisms of resveratrol-induced platelet apoptosis. Cardiovasc Res 83: 575-585, 2009.
23. Zou J, Huang Y, Cao K, et al: Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model. Life Sci 68: 153-163, 2000.
24. Choi KH, Kim JE, Song NR, et al: Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovasc Res 85: 836-844, 2010.
25. Hsieh TC, Juan G, Darzynkiewicz Z and Wu JM: Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 59: 2596-2601, 1999.
26. Bruder JL, Hsieh T, Lerea KM, Olson SC and Wu JM: Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. BMC Cell Biol 2: 1, 2001.
27. Klinge CM, Wickramasinghe NS, Ivanova MM and Dougherty SM: Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 22: 2185-2197, 2008.
28. Aird WC: Endothelium as an organ system. Crit Care Med 32: S271-S279, 2004.
29. Aird WC: Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res 98: 159-162, 2006. (Pubitemid 43755343)
30. Aird WC: Endothelial cell heterogeneity and atherosclerosis. Curr Atheroscler Rep 8: 69-75, 2006.
31. Aird WC: Endothelial cell heterogeneity. Crit Care Med 31: S221-S230, 2003.
32. DiPietrantonio AM, Hsieh TC and Wu JM: Specific processing of poly(ADP-ribose) polymerase, accompanied by activation of caspase-3 and elevation/reduction of ceramide/hydrogen peroxide levels, during induction of apoptosis in host HL-60 cells infected by the human granulocytic ehrlichiosis (HGE) agent. IUBMB Life 49: 49-55, 2000.
33. Hsieh TC, Kunicki J, Darzynkiewicz Z and Wu JM: Effects of extracts of Coriolus versicolor (I'm-Yunity) on cell-cycle progression and expression of interleukins-1 beta,-6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes. J Altern Complement Med 8: 591-602, 2002.
34. Hsieh TC, Wu P, Park S and Wu JM: Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP). BMC Complement Altern Med 6: 30, 2006.
35. DiPietrantonio AM, Hsieh TC, Olson SC and Wu JM: Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR). Int J Cancer 78: 53-61, 1998.
36. Darzynkiewicz Z, Bedner E and Smolewski P: Flow cytometry in analysis of cell cycle and apoptosis. Semin Hematol 38: 179-193, 2001. (Pubitemid 32319316)
37. Hsieh TC, Lu X, Wang Z and Wu JM: Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med Chem 2: 275-285, 2006.
38. Lu X, Guo J and Hsieh TC: PC-SPES inhibits cell proliferation by modulating p21, cyclins D, E and B and multiple cell cycle-related genes in prostate cancer cells. Cell Cycle 2: 59-63, 2003.
39. Hsieh TC, Lu X, Guo J, et al: Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies. Int J Oncol 20: 681-689, 2002.
40. Wang Z, Chen Y, Labinskyy N, Hsieh TC, Ungvari Z and Wu JM: Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts. Biochem Biophys Res Commun 346: 367-376, 2006. (Pubitemid 43866007)
41. Haider UG, Sorescu D, Griendling KK, Vollmar AM and Dirsch VM: Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol Pharmacol 63: 925-932, 2003.
42. Haider UG, Sorescu D, Griendling KK, Vollmar AM and Dirsch VM: Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 62: 772-777, 2002.
43. Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M and Masuyama T: Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 296: H585-H593, 2009.
44. Walker JL, Loscalzo J and Zhang YY: 5-Lipoxygenase and human pulmonary artery endothelial cell proliferation. Am J Physiol Heart Circ Physiol 282: H585-H593, 2002. (Pubitemid 34654982)
45. Iwase M, Uechi M, Vatner DE, et al: Cardiomyopathy induced by cardiac Gs alpha overexpression. Am J Physiol 272: H585-H589, 1997. (Pubitemid 127750094)